Preclinical and clinical pharmacology of rosuvastatin, a new 3-hydroxy- 3-methylglutaryl coenzyme A reductase inhibitor11CRESTOR is a trademark, the property of AstraZeneca PLC. Research discussed in this article was supported by AstraZeneca. 论文

2001The American Journal of Cardiology引用 415
DOI
Lipoproteins and Cardiovascular HealthComputational Drug Discovery MethodsCancer, Lipids, and Metabolism
Computational Drug Discovery MethodsLipoproteins and Cardiovascular HealthCancer, Lipids, and Metabolism
相关技术:Computational Drug Discovery Methods
关系图谱

Preclinical and clinical pharmacology of rosuvastatin, a new 3-hydroxy- 3-methylglutaryl coenzyme A reductase inhibitor11CRESTOR is a trademark, the property of AstraZeneca PLC. Research discussed in this article was supported by AstraZeneca. · 相关事件

暂无数据